Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy Post author:Sam Post published:February 7, 2018 Post category:BioPharma The FDA approved Gilead’s triple combination treatment for HIV, Biktarvy. Source: BioSpace You Might Also Like Production Problems Lead Pacira to Cut Jobs in San Diego July 9, 2017 Roche Reports Death in Phase III Hemophilia Study February 22, 2017 Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and… December 5, 2017
Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and… December 5, 2017
